Why it Matters
The House Ways and Means Committee is set to put U.S. Trade Representative Jamieson Greer in the hot seat on April 22, as the Trump administration's tariff-heavy trade agenda faces its most direct congressional scrutiny yet. With committee members on both sides of the aisle actively pushing legislation to claw back congressional authority over trade, and industries from pharmaceuticals to agriculture flooding Capitol Hill with lobbying dollars, the hearing is shaping up as a flashpoint over who controls American trade policy — the White House or Congress.
The Policy Fault Lines
The divide on the committee is sharp. Democratic members have spent the past month publicly hammering the administration's tariff posture. Rep. Jimmy Panetta (D-CA-19), a member of the Ways and Means Trade Subcommittee, has been among the most vocal. He introduced the bipartisan "Stop Global Tariffs Act" on April 12 to block the administration's tariffs, and separately promoted his "Reclaim Our Trade Powers Act" to restore congressional authority over trade. In between, he argued that tariffs are "wiping out manufacturing jobs" and called on Congress to "take back its authority over trade."
Rep. Steven Horsford (D-NV-4) met with Canada's Consul General in late March to discuss the tariffs' effects on Nevada families, and Rep. Lloyd Doggett (D-TX-37) raised concerns in mid-April about trade benefits being stripped from countries in connection with the administration's deportation policies.
Across the aisle, Republican members have been more focused on agricultural market access. Rep. Randy Feenstra (R-IA-4) discussed protecting biosecurity and trade for Iowa farmers at the end of March, and highlighted "trade wins" in the Farm Bill in early April, pointing to legislation aimed at expanding access to foreign markets.
In all, 15 Democratic and 10 Republican committee members posted communications touching on trade or tariff topics in the 30 days leading up to the hearing — a level of pre-hearing engagement that reflects how much pressure members are hearing from constituents and industries back home.
Who's Lobbying, and What They Want
The congressional hearing today, April 22, arrives against a backdrop of sustained industry lobbying on trade. Disclosures filed over the past year reveal a broad cross-section of sectors pressing their case on the Trump administration's trade agenda.
Kyowa Kirin Inc., a pharmaceutical company, reported $180,000 in lobbying on "tariffs and trade policy" in the third quarter of 2025 — one of the larger single-filer amounts in the set. Lam Research Corp., a semiconductor equipment manufacturer, filed $80,000 in the fourth quarter of 2025 on "export controls, trade enforcement and CFIUS modernization." Business Roundtable Inc. reported $60,000 in the fourth quarter of 2025 on issues including trade policy, tax policy, and government funding.
Agricultural interests have also been active. American Pistachio Growers filed $30,000 in the fourth quarter of 2025 and another $30,000 in the first quarter of 2026 on farm bill and agricultural trade policy. The group's political action committee has contributed $4,000 to Ways and Means Committee Chair Jason Smith (R-MO-8) and $6,000 to Rep. Panetta over the past two years.
The Canadian American Business Council has filed lobbying disclosures in each of the past four quarters — $10,000 per quarter — on "issues regarding trade and commerce between the U.S. and Canada; tariffs," with its most recent first quarter 2026 filing adding "cross-border policy issues" to the list. The consistency of those filings tracks directly with the escalating tensions over U.S.-Canada trade relations that Rep. Horsford raised in his March meeting with Canada's Consul General.
The Witness and the Committee
USTR Jamieson Greer will appear as the sole witness before the full committee, chaired by Rep. Jason Smith (R-MO-8), with Rep. Richard Neal (D-MA) serving as ranking member. The hearing is scheduled for 2:00 p.m. in 1100 Longworth House Office Building.
The full committee format — rather than a subcommittee hearing — signals the breadth of congressional interest. With nearly four dozen members eligible to question Greer, the hearing gives both parties a platform to press the administration on everything from the economic effects of broad tariff actions to the status of bilateral negotiations and the legal basis for executive trade authority.
For Democrats, the central question is likely to be whether the administration's tariff strategy is delivering results or simply transferring costs to American businesses and consumers. For Republicans — particularly those representing agricultural districts — the pressure point is market access: whether the administration's trade posture is opening doors or closing them for U.S. exporters.
Greer will face questions from members who have spent the past month publicly staking out positions, introducing legislation, and meeting with foreign officials. The Ways and Means Committee trade hearing on April 22 is less a fact-finding exercise than a public accounting — and the administration's answers will land in a Congress that is already drafting bills to limit its own deference on trade.
Access the Legis1 platform for comprehensive political news, data, and insights.